Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Oft

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Seminars in Immunology|November 11, 2019
Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experienceMartin Oft
Cancer Immunology Research|April 30, 2014
IL-10: master switch from tumor-promoting inflammation to antitumor immunityMartin Oft
Current Oncology Reports|February 22, 2019
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer TherapeuticsKaren Autio, Martin Oft
Current Topics in Microbiology and Immunology|May 22, 2010
Subversion and coercion: the art of redirecting tumor immune surveillanceJohn B Mumm, Martin Oft
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 14, 2013
Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicityJohn B Mumm, Martin Oft
Nature Cell Biology|July 10, 2002
Metastasis is driven by sequential elevation of H-ras and Smad2 levelsMartin Oft, Rosemary J Akhurst, Allan Balmain
Oncoimmunology|December 25, 2012
Killing from withinJohn B Mumm, Jan Emmerich, Martin Oft
Oncoimmunology|December 25, 2012
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cellsJan Emmerich, John B Mumm, Martin Oft
Trends in Immunology|March 31, 2007
Swords into plowshares: IL-23 repurposes tumor immune surveillanceJohn L Langowski, Robert A Kastelein, Martin Oft
Frontiers in Immunology|August 8, 2024
IL-2 based cancer immunotherapies: an evolving paradigmSushama Rokade, Anita Mehta Damani, Martin Oft, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Seminars in Immunology|November 11, 2019
Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experienceMartin Oft
Cancer Immunology Research|April 30, 2014
IL-10: master switch from tumor-promoting inflammation to antitumor immunityMartin Oft
Current Oncology Reports|February 22, 2019
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer TherapeuticsKaren Autio, Martin Oft
Current Topics in Microbiology and Immunology|May 22, 2010
Subversion and coercion: the art of redirecting tumor immune surveillanceJohn B Mumm, Martin Oft
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 14, 2013
Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicityJohn B Mumm, Martin Oft
Nature Cell Biology|July 10, 2002
Metastasis is driven by sequential elevation of H-ras and Smad2 levelsMartin Oft, Rosemary J Akhurst, Allan Balmain
Oncoimmunology|December 25, 2012
Killing from withinJohn B Mumm, Jan Emmerich, Martin Oft
Oncoimmunology|December 25, 2012
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cellsJan Emmerich, John B Mumm, Martin Oft
Trends in Immunology|March 31, 2007
Swords into plowshares: IL-23 repurposes tumor immune surveillanceJohn L Langowski, Robert A Kastelein, Martin Oft
Frontiers in Immunology|August 8, 2024
IL-2 based cancer immunotherapies: an evolving paradigmSushama Rokade, Anita Mehta Damani, Martin Oft, et al.
Pageof 3